Lumito secures loan of SEK 20 million and carries out an issue of warrants free-of-charge to shareholders and the lender
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, BELARUS, RUSSIA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER […]
Change of mentor to Mangold Fondkommission
Lumito AB has entered into an agreement with Mangold Fondkommission AB to act as the company's mentor in trading on NGM Nordic SME. Mangold Fondkommission will take over as mentor for the company on 15 October 2021. Lumito has simultaneously terminated the agreement with G&W Fondkommission AB, which expired on 14 October 2021. For further […]
Lumito initiates process for listing on Nasdaq First North Growth Market
The Lund-based medical device company Lumito AB has initiated a process to list the Company's shares and warrants on Nasdaq First North Growth Market. As part of this process, a conditional application for delisting from NGM Nordic SME has been submitted to NGM. The application is conditional on Nasdaq’s approval of Lumito for listing on […]
Last day of trading of Lumito TO1 subscription warrants
The last day of trading of Lumito AB (publ) TO1 is Wednesday, 3 July 2019. According to the terms and conditions for series Lumito TO1 subscription warrants, the subscription price shall be reassessed under certain conditions, such as when a preferential rights issue takes place during the warrant life of Lumito TO1. Since Lumito has […]
The last day of trading of paid subscription units (BTU)
The last day of trading of Lumito AB (publ) paid subscription units (BTU) is Tuesday, 2 July 2019. The preferential rights issue that was conducted during May/June 2019 has now been registered with the Swedish Companies Registration Office. The new shares and warrants (after conversion from paid subscription units) are expected to be delivered to […]
Reassessment of subscription price for Lumito TO1 subscription warrants
According to the terms and conditions for series Lumito TO1 subscription warrants, the subscription price shall be reassessed under certain conditions, such as when a preferential rights issue takes place during the warrant life of Lumito TO1. Since Lumito has recently conducted a preferential rights issue, the subscription price for LUMITO TO1 has been reassessed […]
Lumito AB is provided approximately MSEK 38.7 in cash through an over-subscribed rights issue and a decided over-allotment
Lumito AB (publ) announces today that the Company's new share issue amounting to approximately MSEK 35.7 has been subscribed to a total of 155 percent. The commitments from the guarantee consortium do therefore not have to be utilized. In addition, an over-allotment issue of MSEK 3.0 has been decided. An extraordinary general meeting of Lumito […]
Lumito’s public new share issue oversubscribed
Lumito AB’s recently completed public new share issue resulted in the subscription of units (share plus warrant) for a total value of approximately MSEK 20.4 before transaction costs. This corresponds to a subscription rate of 102 percent of the offering. – We are very happy with the outcome, says Lumito’s CEO, Stefan Nilsson. – Considering […]
The Board of Directors’s adjusted proposal for authorization to resolve on new issues
The Board of Directors of Lumito AB (publ) has decided to adjust its proposal under the item 10 on the agenda for the annual general meeting on 4 June 2019. The adjustment means that the following passage is removed: ” Such new issues may in total be comprised of at most the equivalent of 11,200,000 […]
Lumito publishes prospectus for preferential rights issue
This press release may not be announced, published or distributed, either directly or indirectly, in or to the United States, Australia, Japan, New Zealand, South Africa, The Republic of Korea, Canada or any other country in which such action is wholly or partly subject to legal restrictions. In order to facilitate and accelerate the development […]
